According to Zhitong Finance App, Yasheng Pharmaceutical (06855.HK) issued an announcement. On October 15, 2026, the trustee announced that on October 15, 2026, the purpose of the 2022 restricted share unit plan was to purchase a total of 200,000 existing shares on the market to satisfy the restricted share units after ownership.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.